About Jubilant Bhartia Group
Jubilant Bhartia Group is a Healthcare company based in Noida (India) founded in 1978 by Hari S Bhartia and Shyam S Bhartia. It operates as a CDMO focused on manufacturing API products for the biopharma sector. It operates on a B2B model. The company has 1 employees. Its Indian entity Jubilant First Trust Healthcare Limited reported revenue of ₹60.6 Lakh. Its focus areas include Biopharmaceuticals, Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma and 3 more; 5 of its 8 listed similar companies have raised funding.
Company details
Jubilant Bhartia Group, founded in 1978 in Noida, India, focuses on providing healthcare solutions, biopharmaceuticals, producing manufactured goods, and api production. Operates as a CDMO focused on manufacturing API products for the biopharma sector. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Noida, India
- Employees 1
- Founders Hari S Bhartia, Shyam S Bhartia
- SectorsHealthcare
- Email••••••••
- Website jubilantbhartia.com
- Legal Name Jubilant First Trust Healthcare Limited
- Date of Incorporation 09 Jan, 2006
- Jurisdiction Noida, Uttar Pradesh, India
- Annual Revenue₹60.6 Lakh
FY 2023
- Net Profit₹57.4 Lakh
FY 2023 · 95% margin
- EBITDA-₹2.9 Lakh
FY 2023 · -5% margin
- Employee Count1
Associated legal entities of Jubilant Bhartia Group
Jubilant Bhartia Group operates through Jubilant First Trust Healthcare Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jubilant First Trust Healthcare Limited CIN U74110UP2006PLC035993 | Active | 09 Jan 2006 | Noida, Uttar Pradesh | ₹0.6 Cr | – | 3 | View details |
Board of directors of Jubilant First Trust Healthcare Limited (Jubilant Bhartia Group)
Jubilant First Trust Healthcare Limited is the primary company behind Jubilant Bhartia Group. The board of Jubilant First Trust Healthcare Limited currently have 3 directors; the longest-serving is Sanjay Gupta, appointed in 2015. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Gupta DIN 00095510 | Director | 24 Mar 2015 | 11 yrs 6 mo | Jubilant First Trust Healthcare Limited |
| Arun Kumar Sharma DIN 06991435 | Director | 01 Feb 2021 | 5 yrs 8 mo | Jubilant First Trust Healthcare Limited |
| Devarajan Jagannathan DIN 09244642 | Director | 01 Dec 2022 | 3 yrs 10 mo | Jubilant First Trust Healthcare Limited |
People of Jubilant Bhartia Group
7 people are tracked at Jubilant Bhartia Group (5 in leadership, 2 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Hari S Bhartia | Co-Founder | Leadership |
Shyam S Bhartia | Co-Founder | Leadership |
Ajay Neb | Head Corporate Affairs -jubilant Bhartia Group | Leadership |
Dr. Amit Jindal | Chief Of Staff | Leadership |
Rahul Jindal | Senior Director - Strategy Office | Leadership |
Shyam Bhartia | Chairman & MD | Team |
Dr. Sunil R Parekh – D. Litt. | Strategic Advisor | Team |
Complete people profiles for Jubilant Bhartia Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Jubilant Bhartia Group
Figures of Jubilant First Trust Healthcare Limited, the primary company behind Jubilant Bhartia Group, for FY 2023. Revenue was ₹60.6 Lakh. Net profit was ₹57.4 Lakh (95% margin). EBITDA was -₹2.9 Lakh (-5% margin).
- ₹60.6 LakhRevenue · FY 2023
- ₹57.4 LakhNet profit · 95% margin
- -₹2.9 LakhEBITDA · -5% margin
- ₹2.05 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Jubilant First Trust Healthcare Limited are on its company page.
Detailed financial statements for Jubilant Bhartia Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Jubilant Bhartia Group
Jubilant Bhartia Group has 8 listed similar companies in our database, 5 of them funded. They include Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| apicore.com | 2004 | Somerset, United States | $720,118 | 518 | APIs are manufactured and custom synthesis services are provided. | |
| bellenchem.com | 2007 | Beijing, China | $52.56M | – | APIs and intermediates are researched and manufactured, specializing in heterocycles. |
Detailed similar companies of Jubilant Bhartia Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Jubilant Bhartia Group
The website of Jubilant Bhartia Group (jubilantbhartia.com) receives about 5.1K visits a month.
- Monthly visits5.1K
▲ 59.6% vs previous month
Websites whose visitors overlap most with Jubilant Bhartia Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| jubilantindustries.com | 35% | 1.9K | #8,593,046 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Jubilant Bhartia Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jubilant Bhartia Group
Complete news archive for Jubilant Bhartia Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jubilant Bhartia Group
Jubilant Bhartia Group was founded in 1978.
Jubilant Bhartia Group is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Jubilant Bhartia Group has 1 employees.
The primary company behind Jubilant Bhartia Group, Jubilant First Trust Healthcare Limited, reported revenue of ₹60.6 Lakh for FY 2023.
Jubilant Bhartia Group, founded in 1978 in Noida, India, focuses on providing healthcare solutions, biopharmaceuticals, producing manufactured goods, and api production. Operates as a CDMO focused on manufacturing API products for the biopharma sector. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Jubilant Bhartia Group's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Jubilant Bhartia Group operates through Jubilant First Trust Healthcare Limited.
The legal entities of Jubilant Bhartia Group currently have 3 directors, including Sanjay Gupta, Arun Kumar Sharma, Devarajan Jagannathan.